Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Inspire Medical Systems's Enterprise Value is €1,178.5 Mil.
Inspire Medical Systems's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €134.5 Mil. Therefore, Inspire Medical Systems's EV-to-OCF for today is 8.76.
The historical rank and industry rank for Inspire Medical Systems's EV-to-OCF or its related term are showing as below:
FRA:2DR'
s EV-to-OCF Range Over the Past 10 Years
Min: -983.23 Med: -39.09 Max: 634.33
Current: 8.65
During the past 11 years, the highest EV-to-OCF of Inspire Medical Systems was 634.33. The lowest was -983.23. And the median was -39.09.
FRA:2DR's EV-to-OCF is ranked worse than 52.52% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.94
vs FRA:2DR: 8.65
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Inspire Medical Systems (FRA:2DR) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Inspire Medical Systems's PE Ratio (TTM) for today is calculated as:
Inspire Medical Systems's share price for today is €48.60.
Inspire Medical Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.942.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Inspire Medical Systems's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspire Medical Systems EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Inspire Medical Systems's EV-to-OCF falls into.
Inspire Medical Systems's current Enterprise Value is €1,178.5 Mil.
Inspire Medical Systems's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €134.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspire Medical Systems (FRA:2DR) has a EV-to-OCF of 8.76 as of Aug. 15, 2026. According to the industry distribution chart, Inspire Medical Systems ranks #448 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 52.5%.
Is Inspire Medical Systems' EV-to-OCF too high?
Inspire Medical Systems' current EV-to-OCF is 8.76. The Medical Devices & Instruments industry median EV-to-OCF is 7.94. Inspire Medical Systems' value of 8.76 is 10.3% above this industry median. Based on the distribution chart, Inspire Medical Systems ranks #448 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Inspire Medical Systems has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' EV-to-OCF compare to AHCO and IART?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #448 out of 853 companies for EV-to-OCF. This places Inspire Medical Systems in the lower half of its industry. The industry median EV-to-OCF is 7.94. Inspire Medical Systems' value of 8.76 is 10.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.94, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspire Medical Systems's current EV-to-OCF of 8.76 is 10.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspire Medical Systems's current EV-to-OCF is 8.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Inspire Medical Systems (FRA:2DR) has a current EV-to-OCF of 8.76. The stock's GF Value™ is €162.88, compared to a current price of €48.60 — trading 70.2% below its estimated fair value. The current EV-to-OCF is 8.76 and 10.3% above the Medical Devices & Instruments industry median of 7.94. Inspire Medical Systems' overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Inspire Medical Systems (FRA:2DR), the current EV-to-OCF is 8.76 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspire Medical Systems (FRA:2DR) Overvalued in 2026?
Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued.
The current stock price of €48.60 is trading 70.2% below its estimated GF Value™ of €162.88.
Key valuation signals for FRA:2DR:
EV-to-OCF: 8.76
GF Value™: €162.88 vs. price of €48.60 (70.2% below fair value)
Industry Position: 10.3% above the Medical Devices & Instruments median (#448 of 853)
No single metric tells the full story. See the FRA:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
57GF Score
Get the complete analysis for FRA:2DR
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2DR has been successfully added to your 
